Ceplene histamine dihydrochloride regulatory update

EpiCept requested re-examination of the negative opinion from EMEA’s CHMP on an MAA for Ceplene histamine dihydrochloride in conjunction with interleukin-2 (IL-2) to maintain the first remission in p...